Daveen Chopra - 22 May 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: CVP, TMTT & Surgical
Issuer ticker: EW
Reported as of: 22 May 2026
Net transaction value: -$126,905
SEC form: 4
Accepted by SEC: 22 May 2026, 16:35:58 UTC
Prior SEC filing: 12 May 2026
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Daveen Chopra filed Form 4 for Edwards Lifesciences Corp (EW) on 22 May 2026.

Key facts

This page summarizes Daveen Chopra's Form 4 filing for Edwards Lifesciences Corp (EW).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 May 2026, 16:35.

Change

Previous filing in this sequence was filed on 12 May 2026.
Current net transaction value: -$126,905.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001740963 Primary reporting owner

Chopra Daveen

Relationship: CVP, TMTT & Surgical
Address: ONE EDWARDS WAY, IRVINE
Signature: Linda J. Park, Attorney-in-Fact
Signature date: 22 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Sale

Transaction value: $126,905
Shares: -1,500
Change %: -3.3%
Price: $84.60
Shares after: 44,324
Date: 22 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple trades at prices ranging from $84.6002 to $84.6050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.